002626 logo

Xiamen Kingdomway Group Company Stock Price

SZSE:002626 Community·CN¥12.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

002626 Share Price Performance

CN¥20.14
3.62 (21.91%)
CN¥20.14
3.62 (21.91%)
Price CN¥20.14

002626 Community Narratives

There are no narratives available yet.

Recent 002626 News & Updates

Xiamen Kingdomway Group (SZSE:002626) Could Easily Take On More Debt

Jan 07
Xiamen Kingdomway Group (SZSE:002626) Could Easily Take On More Debt

Xiamen Kingdomway Group Company Key Details

CN¥3.4b

Revenue

CN¥2.1b

Cost of Revenue

CN¥1.3b

Gross Profit

CN¥888.5m

Other Expenses

CN¥459.2m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 25, 2025
Earnings per share (EPS)
0.75
Gross Margin
39.12%
Net Profit Margin
13.33%
Debt/Equity Ratio
36.7%

Xiamen Kingdomway Group Company Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Excellent balance sheet established dividend payer.

1 Risk
3 Rewards

About 002626

Founded
1997
Employees
2123
CEO
Bin Jiang
WebsiteView website
www.kingdomway.com

Xiamen Kingdomway Group Company engages in the manufacturing and sale of the nutrition and health products in China and internationally. It offers its products under the Doctor’s Best, Zipfizz, Kingdomway, Labrada, Prosupps, Maikon, and Jinlexin brands. The company was formerly known as Xiamen Jindawei Vitamin Co., Ltd. Xiamen Kingdomway Group Company was founded in 1997 and is based in Xiamen, China.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Chinese Market Performance

  • 7 Days: 0%
  • 3 Months: 17.2%
  • 1 Year: 15.8%
  • Year to Date: 26.2%
The market has been flat over the last week. More promisingly, the market is up 16% over the past year. As for the next few years, earnings are expected to grow by 27% per annum. Market details ›